Merseburger AS - Search Results

1

Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.

Seidel C, Fenner M, Merseburger AS, Reuter C, Ivanyi P, Länger F, Ganser A, Grünwald V. Seidel C, et al. Among authors: merseburger as. World J Urol. 2011 Jun;29(3):355-60. doi: 10.1007/s00345-010-0642-3. Epub 2011 Jan 22. World J Urol. 2011. PMID: 21258806

2

Surgical bladder preserving strategies in the treatment of muscle-invasive bladder cancer.

Kuczyk M, Machtens S, Bokemeyer C, Kollmannsberger C, Hartmann J, Kondoh M, Merseburger A, Jonas U. Kuczyk M, et al. World J Urol. 2002 Aug;20(3):183-9. doi: 10.1007/s00345-002-0278-z. Epub 2002 Jul 12. World J Urol. 2002. PMID: 12196902 Review.

3

Late relapse after treatment for nonseminomatous testicular germ cell tumors according to a single center-based experience.

Kuczyk MA, Bokemeyer C, Kollmannsberger C, Corvin S, Anastasiadis A, Machtens S, Merseburger A, Wegener G, Stenze A, Hartmann JT, Jonas U. Kuczyk MA, et al. World J Urol. 2004 Apr;22(1):55-9. doi: 10.1007/s00345-003-0353-0. World J Urol. 2004. PMID: 15218878

4

Impact of tumor size on the long-term survival of patients with early stage renal cell cancer.

Kuczyk M, Wegener G, Merseburger AS, Anastasiadis A, Machtens S, Zumbrägel A, Hartmann JT, Bokemeyer C, Jonas U, Stenzl A. Kuczyk M, et al. Among authors: merseburger as. World J Urol. 2005 Feb;23(1):50-4. doi: 10.1007/s00345-004-0483-z. Epub 2005 Feb 24. World J Urol. 2005. PMID: 15729558

5

The rationale for radical cystectomy as primary therapy for T4 bladder cancer.

Nagele U, Anastasiadis AG, Merseburger AS, Corvin S, Hennenlotter J, Adam M, Sievert KD, Stenzl A, Kuczyk MA. Nagele U, et al. Among authors: merseburger as. World J Urol. 2007 Aug;25(4):401-5. doi: 10.1007/s00345-007-0172-9. Epub 2007 May 25. World J Urol. 2007. PMID: 17525849

6

Changing concepts in the surgery of renal cell carcinoma.

Merseburger AS, Kuczyk MA. Merseburger AS, et al. World J Urol. 2008 Apr;26(2):127-33. doi: 10.1007/s00345-008-0238-3. Epub 2008 Feb 12. World J Urol. 2008. PMID: 18265990

7

[Value of targeted therapies for renal cell cancer].

Merseburger AS, Kuczyk MA. Merseburger AS, et al. Urologe A. 2008 Oct;47(10):1303-10. doi: 10.1007/s00120-008-1746-x. Urologe A. 2008. PMID: 18587556 Review. German.

8

Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival.

Merseburger AS, Kramer MW, Hennenlotter J, Serth J, Kruck S, Gracia A, Stenzl A, Kuczyk MA. Merseburger AS, et al. World J Urol. 2008 Dec;26(6):637-42. doi: 10.1007/s00345-008-0294-8. Epub 2008 Jul 2. World J Urol. 2008. PMID: 18594826

9

An update on the medical therapy of advanced metastatic renal cell carcinoma.

Kruck S, Merseburger AS, Gakis G, Kramer MW, Stenzl A, Kuczyk MA. Kruck S, et al. Among authors: merseburger as. Scand J Urol Nephrol. 2008;42(6):501-6. doi: 10.1080/00365590802203983. Scand J Urol Nephrol. 2008. PMID: 18615363 Review.

10

[Value of lymph node dissection for renal cell carcinoma].

Matuschek I, Merseburger AS, Kuczyk MA. Matuschek I, et al. Among authors: merseburger as. Urologe A. 2009 Jan;48(1):46-50. doi: 10.1007/s00120-008-1759-5. Urologe A. 2009. PMID: 19066837 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters